Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Myasthenia Gravis
Pharma
J&J's Imaavy wins FDA green light in myasthenia gravis
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis.
Fraiser Kansteiner
Apr 30, 2025 10:51am
FDA approves argenx's prefilled syringe version of Vyvgart
Apr 11, 2025 11:00am
Argenx banks on Vyvgart prefilled syringe approval in 2025: exec
Feb 19, 2025 1:36pm
Argenx sees early launch success for Vyvgart in CIDP
Nov 1, 2024 11:46am
Amgen's Uplizna posts strong results in myasthenia gravis trial
Sep 25, 2024 11:37am
Argenx's Vyvgart holds its own against AZ's rare disease duo
Jul 25, 2024 3:16pm
